United States · Funded startup
5 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$80Mraised across 5 rounds since 2010, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
OrbiMed
RA Capital Management
Frazier Healthcare Partners
Vivo Ventures
Capital MidwestFrom a historical funding recordSEC filing: $60M sold, first sale Apr 2014
From a historical funding recordSEC filing: $11M sold, first sale Dec 2013
No investor was named in the report.
Reported by sec.govSEC filing: $4.3M sold, first sale Mar 2012
No investor was named in the report.
From a historical funding recordSEC filing: $1.7M sold, first sale Aug 2008
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Capital MidwestOrbiMedRA Capital ManagementFrazier Healthcare PartnersVivo VenturesJanus Capital GroupApjohn Ventures Fund, LPHopen Life Science VenturesThe Amherst FundMissing a round, or an investor who was in one? Tell us.
ProNAi Therapeutics's investors include Capital Midwest, OrbiMed, RA Capital Management, Frazier Healthcare Partners and Vivo Ventures, and 4 more on record.
ProNAi Therapeutics has raised $80M across 5 rounds since 2010.
ProNAi Therapeutics's most recent round was a Debt of $2.7M in Mar 2015.
ProNAi Therapeutics's largest round on record is $60M (Series D), in Apr 2014.
ProNAi Therapeutics's first round on record, in Jan 2014, was backed by Capital Midwest.
ProNAi Therapeutics's latest named round is a Debt, in Mar 2015.
ProNAi Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·